BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM;OMEICOS THERAPEUTICS GMBH;MAX DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN
发明人:
FISCHER, ROBERT,KONKEL, ANNE,WESSER, TIM,WESTPHAL, PHILIPP,SCHUNK, WOLF-HAGEN,WESTPHAL, CHRISTINA,FALCK, JOHN RUSSEL
申请号：
CA2992825
公开号：
CA2992825A1
申请日:
2016.07.22
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention relates to compounds according to general formula (I) which are metabolically robust analogues of bioactive lipid mediators derived from omega-3 polyunsaturated fatty acids (n-3 PUFAs).The present invention further relates to compositions containing one or more of these compounds and to the use of these compounds or compositions for the treatment or prevention of cardiovascular diseases.
